NetScientific plc
NSCI.L · London Stock Exchange · GBp
53,12GBp
−0,38 (−0,71 %)Stand 25. Sept., 13:07
Kennzahlen
- Eröffnung
- 53,15
- Vortag
- 53,50
- Tagesspanne
- 53,12 – 53,15
- 52 Wochen
- 48,00 – 80,50
- Volumen
- 4644
- Ø Volumen
- 18.498
- Börsenwert
- 12,72 Mio. p
- KGV
- –
- Gewinn je Aktie (TTM)
- –
- Dividendenrendite
- –
- Beta
- 1,7
- Nächste Zahlen
- –
Finanzen
Gerade nicht verfügbar.
Bewertung
Gerade nicht verfügbar.
Analysten
Einstufungen
Gerade nicht verfügbar.
Kursziel
Gerade nicht verfügbar.
Quartalszahlen
| Okt. 2023 | Sept. 2022 | Sept. 2021 | |
|---|---|---|---|
| Gewinn je Aktie · Erwartet | – | – | – |
| Gewinn je Aktie · Tatsächlich | -0,06 | -0,07 | -0,08 |
| Abweichung | – | – | – |
| Umsatz · Tatsächlich | 770.000 | 391.000 | 407.000 |
Dividenden und Splits
Keine Dividenden gezahlt.
Aktiensplits
- 25. Aug. 20201:10
Eigentümer
Institutionen
Gerade nicht verfügbar.
Insider-Geschäfte
–
Vergleichbare Unternehmen
AVO.LAdvanced Oncotherapy plc1,75−9,09 %
BVX.LBiVictriX Therapeutics Plc10,00+17,65 %
CEL.LCeladon Pharmaceuticals Plc13,40+16,52 %
DEST.LDestiny Pharma plc3,00−25,00 %
INHC.LInduction Healthcare Group PLC9,75−1,32 %
MXC.LMGC Pharmaceuticals Limited21,20−3,64 %
OKYO.LOKYO Pharma Limited1,40−24,32 %
SNG.LSynairgen plc0,950,00 %
Über das Unternehmen
NetScientific plc operates as a venture capital entity, strategically deploying capital into companies at their initial, emergent, and growth stages. Its primary investment interests lie in sustainability, advanced technology, and groundbreaking biomedical and healthcare innovations. Within the healthcare sphere, the firm specifically targets digital health, diagnostics, and therapeutics, with a particular emphasis on ventures that enhance the well-being and health outcomes for individuals suffering from chronic diseases. Its digital health focus encompasses data analytics, wearable technologies, and various medical devices. Geographically, NetScientific actively seeks opportunities in established European markets and across the United States. While typical investments may reach £15 million (approximately $20.32 million), the firm is prepared to commit larger sums. A core strategy is to secure a controlling interest in its principal subsidiary companies, with funding predominantly sourced from its own balance sheet. NetScientific plc was established in 2008 and is headquartered in London, United Kingdom.
Führung
- Ilian Petkov IlievChief Executive Officer & Executive Director
- Edward Benjamin Peter HooperGeneral Counsel & Executive Director
- Christopher NiehausAdviser
- Ian CookeVenture Partner of Sustainability
- Anete MerheleMarketing Manager
- Hannah JarvisFinancial Controller
- CEO
- Ilian Petkov Iliev
- Mitarbeitende
- 29
- Hauptsitz
- London, GB
- Sektor
- Healthcare
- Branche
- Biotechnology
- Börsengang
- 16. Sept. 2013
- Website
- netscientific.net
Nachrichten
Gerade keine Nachrichten zu diesem Unternehmen.
Kurse mindestens 15 Minuten verzögert. Daten: Financial Modeling Prep. Keine Anlageberatung.